Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2017 August;69(4) > Minerva Ginecologica 2017 August;69(4):357-69

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEW  


Minerva Ginecologica 2017 August;69(4):357-69

DOI: 10.23736/S0026-4784.17.04073-4

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Myomectomy: technique and current indications

Hajanirina RAKOTOMAHENINA 1, José RAJAONARISON 2, Lufee WONG 3, Jean-Luc BRUN 4

1 Department of Obstetrics and Gynecology, University Hospital of Fianarantsoa, Fianarantsoa, Madagascar; 2 Department of Obstetrics and Gynecology, University Hospital of Mahajanga, Mahajanga, Madagascar; 3 Department of Obstetrics and Gynecology, Monash Medical Centre, Clayton, Australia; 4 Department of Obstetrics and Gynecology, University Hospital Pellegrin, Bordeaux, France


PDF  


Uterine fibroids are the commonest benign tumor of the female genital tract. They affect a significant proportion of reproductive aged women and may cause excessive menstrual bleeding, pelvic pain or pressure, and adversely affect reproductive outcomes. However, many women remain asymptomatic. Fibroids are the first indication for hysterectomy, but myomectomy is the most suitable surgical option for women who desire preservation of their fertility potential. Only a selected group of women of childbearing age will benefit from a myomectomy, as the consequences of myomectomy on reproductive function have remained controversial. The purpose of this paper was to review the main surgical approaches for myomectomy, and discuss evidence-based indications for myomectomy in women with fibroids, especially with regards to its impact on fertility and reproductive outcomes. A critical review of the literature pertaining to the surgical approaches of myomectomy and the indications for myomectomy was performed, focusing on their impact on fertility and reproductive outcomes. Myomectomy is useful for the treatment of symptomatic fibroids and in selected women with infertility. Symptomatic submucosal fibroids are classically treated by hysteroscopic resection. Symptomatic intramural and subserosal fibroids may be treated by myomectomy, either by laparotomy or laparoscopy depending on their number and size. Prophylactic myomectomy is not recommended for preventing obstetrical complications or the risk of leiomyosarcoma. Although fibroids may have a negative effect on fertility, only the removal of submucosal fibroids has been consistently shown to improve spontaneous fertility or outcomes of assisted reproduction technology.


KEY WORDS: Uterine myomectomy - Leiomyoma - Fertility - Reproduction

top of page

Publication History

Issue published online: June 8, 2017
Article first published online: April 26, 2017

Cite this article as

Rakotomahenina H, Rajaonarison J, Wong L, Brun JL. Myomectomy: technique and current indications. Minerva Ginecol 2017;69:357-69. DOI: 10.23736/S0026-4784.17.04073-4

Corresponding author e-mail

jean-luc.brun@chu-bordeaux.fr